2014 Q4 Form 10-Q Financial Statement

#000119312514385002 Filed on October 28, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2013 Q3
Revenue $58.26M $50.39M $18.85M
YoY Change 117.08% 167.26% 171.5%
Cost Of Revenue $21.40M $19.90M $4.400M
YoY Change 86.09% 352.27% -13.73%
Gross Profit $36.80M $30.50M $14.40M
YoY Change 140.52% 111.81% 700.0%
Gross Profit Margin 63.17% 60.53% 76.38%
Selling, General & Admin $12.20M $8.800M $4.000M
YoY Change 54.43% 120.0% -2.44%
% of Gross Profit 33.15% 28.85% 27.78%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $12.20M $8.800M $4.700M
YoY Change 54.43% 87.23% 291.67%
Operating Profit $24.60M $21.70M $9.700M
YoY Change 232.43% 123.71% 1516.67%
Interest Expense $9.400M $19.90M $4.407M
YoY Change 213.33% 351.62% -14.38%
% of Operating Profit 38.21% 91.72% 45.43%
Other Income/Expense, Net
YoY Change
Pretax Income $25.40M $23.48M $10.26M
YoY Change 144.23% 128.83% -21.15%
Income Tax $100.0K -$118.0K -$264.0K
% Of Pretax Income 0.39% -0.5% -2.57%
Net Earnings $21.49M $22.02M $8.320M
YoY Change 203.57% 164.71% 18.87%
Net Earnings / Revenue 36.89% 43.71% 44.13%
Basic Earnings Per Share $0.37 $0.45 $0.29
Diluted Earnings Per Share $0.37 $0.45 $0.29
COMMON SHARES
Basic Shares Outstanding 57.68M shares 48.48M shares 28.89M shares
Diluted Shares Outstanding 28.89M shares

Balance Sheet

Concept 2014 Q4 2014 Q3 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $52.00M $63.00M $10.00M
YoY Change 0.0% 530.0% -74.36%
Cash & Equivalents $51.81M $63.34M $10.28M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $52.00M $63.00M $10.00M
YoY Change 0.0% 530.0% -86.49%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $11.00M $15.00M $26.00M
YoY Change -50.0% -42.31% -90.51%
Other Assets $12.00M $11.00M $76.00M
YoY Change 20.0% -85.53% 300.0%
Total Long-Term Assets $4.521B $4.035B $1.567B
YoY Change 109.22% 157.48% 209.13%
TOTAL ASSETS
Total Short-Term Assets $52.00M $63.00M $10.00M
Total Long-Term Assets $4.521B $4.035B $1.567B
Total Assets $4.573B $4.098B $1.577B
YoY Change 106.65% 159.84% 171.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $1.896B $643.0M
YoY Change -100.0% 194.87%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.896B $643.0M
YoY Change 194.87% 64200.0%
LONG-TERM LIABILITIES
Long-Term Debt $3.011B $609.0M $83.00M
YoY Change 1104.4% 633.73% -83.6%
Other Long-Term Liabilities $61.00M $83.00M $47.00M
YoY Change -37.11% 76.6% 27.03%
Total Long-Term Liabilities $3.072B $692.0M $130.0M
YoY Change 785.3% 432.31% -76.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.896B $643.0M
Total Long-Term Liabilities $3.072B $692.0M $130.0M
Total Liabilities $3.072B $2.589B $773.8M
YoY Change 110.97% 234.55% 27.68%
SHAREHOLDERS EQUITY
Retained Earnings -$547.6M -$538.7M -$529.9M
YoY Change 2.13% 1.66%
Common Stock $2.028B $2.023B $1.243B
YoY Change 61.81% 62.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.465B $1.478B $713.3M
YoY Change
Total Liabilities & Shareholders Equity $4.573B $4.098B $1.577B
YoY Change 106.65% 159.84% 171.48%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2013 Q3
OPERATING ACTIVITIES
Net Income $21.49M $22.02M $8.320M
YoY Change 203.57% 164.71% 18.87%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $23.10M $23.50M $10.00M
YoY Change 61.54% 135.0% 96.08%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$545.8M -$418.5M -$532.4M
YoY Change -6.99% -21.39% -2709.8%
Cash From Investing Activities -$545.8M -$418.5M -$532.4M
YoY Change -6.99% -21.39% -2709.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.800M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 511.6M 339.6M 472.9M
YoY Change -16.76% -28.19% -2320.19%
NET CHANGE
Cash From Operating Activities 23.10M 23.50M 10.00M
Cash From Investing Activities -545.8M -418.5M -532.4M
Cash From Financing Activities 511.6M 339.6M 472.9M
Net Change In Cash -11.10M -55.40M -49.50M
YoY Change -126.37% 11.92% -1278.57%
FREE CASH FLOW
Cash From Operating Activities $23.10M $23.50M $10.00M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q3 us-gaap Loans And Leases Receivable Collateral For Secured Borrowings
LoansAndLeasesReceivableCollateralForSecuredBorrowings
2725187000
CY2014Q3 bxmt Common Stock Shares Outstanding Including Stock Equivalents
CommonStockSharesOutstandingIncludingStockEquivalents
57792991 shares
CY2014Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
63343000
CY2014Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
0
CY2014Q3 us-gaap Participating Mortgage Loans Participation Liabilities Amount
ParticipatingMortgageLoansParticipationLiabilitiesAmount
447977000
CY2014Q3 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
433738000
CY2014Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
0
CY2014Q3 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
3906226000
CY2014Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
10855000
CY2014Q3 us-gaap Interest Receivable And Other Assets
InterestReceivableAndOtherAssets
103059000
CY2014Q3 us-gaap Assets
Assets
4098473000
CY2014Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1509859000
CY2014Q3 us-gaap Assets Sold Under Agreements To Repurchase Carrying Amounts
AssetsSoldUnderAgreementsToRepurchaseCarryingAmounts
226961000
CY2014Q3 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
1669406000
CY2014Q3 us-gaap Members Equity Attributable To Noncontrolling Interest
MembersEquityAttributableToNoncontrollingInterest
32100000
CY2014Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
28892000
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
572000
CY2014Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6205000
CY2014Q3 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
83011000
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-538726000
CY2014Q3 us-gaap Limited Liability Company Llc Members Equity Including Portion Attributable To Noncontrolling Interest
LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest
55000000
CY2014Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
161259000
CY2014Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2022093000
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
1477739000
CY2014Q3 us-gaap Members Equity
MembersEquity
22900000
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4098473000
CY2014Q3 us-gaap Financial Instruments Sold Not Yet Purchased At Fair Value
FinancialInstrumentsSoldNotYetPurchasedAtFairValue
1700000000
CY2014Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
0
CY2014Q3 us-gaap Minority Interest
MinorityInterest
32120000
CY2014Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
2103144000
CY2014Q3 us-gaap Line Of Credit
LineOfCredit
1669406000
CY2014Q3 us-gaap Liabilities
Liabilities
2588614000
CY2014Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
14990000
CY2014Q3 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
19000000
CY2014Q3 us-gaap Asset Backed Securities At Carrying Value
AssetBackedSecuritiesAtCarryingValue
10100000
CY2013Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
803542000
CY2013Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10283000
CY2013Q3 bxmt Common Stock Shares Outstanding Including Stock Equivalents
CommonStockSharesOutstandingIncludingStockEquivalents
28898165 shares
CY2013Q3 bxmt Deferred Stock Units
DeferredStockUnits
96514 shares
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
57194000 shares
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
57194000 shares
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2013Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
40700000
CY2013Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
159524000
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1252986000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
717909000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2212780000
CY2013Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
0
CY2013Q4 us-gaap Minority Interest
MinorityInterest
38841000
CY2013Q4 us-gaap Line Of Credit
LineOfCredit
863622000
CY2013Q4 us-gaap Liabilities
Liabilities
1456030000
CY2013Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
0
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
0
CY2013Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2047223000
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
10096000
CY2013Q4 us-gaap Interest Receivable And Other Assets
InterestReceivableAndOtherAssets
80639000
CY2013Q4 us-gaap Assets
Assets
2212780000
CY2013Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
22480000
CY2014Q3 bxmt Debt Instrument Covenant Requirement On Consolidated Tangible Net Worth Minimum
DebtInstrumentCovenantRequirementOnConsolidatedTangibleNetWorthMinimum
1100000000
CY2014Q3 bxmt Number Of Benefit Plans
NumberOfBenefitPlans
5 Plans
CY2014Q3 bxmt Cash And Cash Equivalents And Restricted Cash At Carrying Value
CashAndCashEquivalentsAndRestrictedCashAtCarryingValue
74198000
CY2014Q3 bxmt Stock Shares Authorized
StockSharesAuthorized
200000000 shares
CY2014Q3 bxmt Repurchase Facility Maximum Borrowing Capacity
RepurchaseFacilityMaximumBorrowingCapacity
2904571000
CY2014Q3 bxmt Deferred Stock Units
DeferredStockUnits
113486 shares
CY2014Q3 bxmt Debt Instrument Covenant Minimum Percentage Of Cash Liquidity On Recourse Indebtedness
DebtInstrumentCovenantMinimumPercentageOfCashLiquidityOnRecourseIndebtedness
0.05 pure
CY2014Q3 bxmt Percentage Of Loans Subject To Yield Maintenance Lock Out Provisions Other Prepayment Restrictions
PercentageOfLoansSubjectToYieldMaintenanceLockOutProvisionsOtherPrepaymentRestrictions
0.88 pure
CY2014Q3 bxmt Underlying Loans Principal Balance
UnderlyingLoansPrincipalBalance
619323000
CY2014Q3 bxmt Equity Investments And Other Receivables Carrying Value
EquityInvestmentsAndOtherReceivablesCarryingValue
13200000
CY2014Q3 bxmt Percentage Of Loans Open To Repayment By Borrower
PercentageOfLoansOpenToRepaymentByBorrower
0.12 pure
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
57679508 shares
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
153453000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15423000
CY2012Q4 bxmt Common Stock Shares Outstanding Including Stock Equivalents
CommonStockSharesOutstandingIncludingStockEquivalents
3016407 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28802000 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28802000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
756750000
CY2013Q4 us-gaap Assets Sold Under Agreements To Repurchase Carrying Amounts
AssetsSoldUnderAgreementsToRepurchaseCarryingAmounts
245731000
CY2013Q4 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
863622000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
288000
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
798000
CY2013Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
97153000
CY2013Q4 us-gaap Participating Mortgage Loans Participation Liabilities Amount
ParticipatingMortgageLoansParticipationLiabilitiesAmount
90000000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
52342000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-536170000
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
3265000
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
169000
us-gaap Profit Loss
ProfitLoss
15696000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16025000
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
1385729000
CY2013Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
159000000
CY2013Q4 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
41500000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14865530 shares
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.27
CY2013Q4 bxmt Common Stock Shares Outstanding Including Stock Equivalents
CommonStockSharesOutstandingIncludingStockEquivalents
29602884 shares
CY2013Q4 bxmt Book Value Of Loans In Maturity Default
BookValueOfLoansInMaturityDefault
27000000
CY2013Q4 bxmt Number Of Loans Maturity Default
NumberOfLoansMaturityDefault
1
CY2013Q4 bxmt Cash And Cash Equivalents And Restricted Cash At Carrying Value
CashAndCashEquivalentsAndRestrictedCashAtCarryingValue
62438000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.53
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
4464000
CY2013Q4 bxmt Underlying Loans Principal Balance
UnderlyingLoansPrincipalBalance
173837000
us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
15000000
us-gaap Dividends Payable Date Declared Day Month And Year
DividendsPayableDateDeclaredDayMonthAndYear
2013-09-30
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
14445000
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
25875000 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
633810000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7953000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
19835000
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
26327000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
5744000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
62150000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-218000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
15696000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
169000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
329000
us-gaap Increase Decrease In Payables Under Repurchase Agreements
IncreaseDecreaseInPayablesUnderRepurchaseAgreements
-261678000
us-gaap Noninterest Expense
NoninterestExpense
9512000
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
-18717000
us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
18772000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1176109000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
633810000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1195694000
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
15000000
us-gaap Share Based Compensation
ShareBasedCompensation
2138000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
7743000
us-gaap Dividends Common Stock
DividendsCommonStock
7776000
us-gaap Management Fee Expense
ManagementFeeExpense
3416000
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1123000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6096000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
7743000
bxmt Proceeds From Loan Origination And Exit Fees
ProceedsFromLoanOriginationAndExitFees
9036000
us-gaap Proceeds From Sale And Collection Of Loans Receivable
ProceedsFromSaleAndCollectionOfLoansReceivable
239631000
bxmt Stock Issued During Period Shares Issuance Of Deferred Shares
StockIssuedDuringPeriodSharesIssuanceOfDeferredShares
6758 shares
us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
11962000
bxmt General And Administrative Expenses Subtotal
GeneralAndAdministrativeExpensesSubtotal
3232000
us-gaap Net Income Loss
NetIncomeLoss
7953000
us-gaap Interest Paid
InterestPaid
4801000
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
64943000
bxmt Reversal Of Provision For Loan Lease And Other Losses
ReversalOfProvisionForLoanLeaseAndOtherLosses
1200000
us-gaap Interest Expense
InterestExpense
6492000
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
3518000
us-gaap Proceeds From Payments For In Securities Sold Under Agreements To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase
580781000
us-gaap Professional Fees
ProfessionalFees
2109000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
38000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1381000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5140000
bxmt Non Cash And Legacy Compensation Expenses
NonCashAndLegacyCompensationExpenses
2138000
bxmt Payment For Settlement Of Interest Rate Swap
PaymentForSettlementOfInterestRateSwap
6123000
bxmt Net Change In Accrued Interest Receivable Prepaid Expenses And Other Assets
NetChangeInAccruedInterestReceivablePrepaidExpensesAndOtherAssets
1182000
bxmt Noncontrolling Interest Increase Decrease From Business Combination
NoncontrollingInterestIncreaseDecreaseFromBusinessCombination
-38913000
bxmt Repayment Of Borrowings On Repurchase Agreements
RepaymentOfBorrowingsOnRepurchaseAgreements
7104000
bxmt Management Incentive Awards Plan
ManagementIncentiveAwardsPlan
1969000
bxmt Expenses Of Consolidated Securitization Vehicles
ExpensesOfConsolidatedSecuritizationVehicles
726000
bxmt Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
3015000
bxmt Proceeds From Borrowings Under Asset Repurchase Agreements
ProceedsFromBorrowingsUnderAssetRepurchaseAgreements
310827000
dei Document Type
DocumentType
10-Q
dei Entity Registrant Name
EntityRegistrantName
BLACKSTONE MORTGAGE TRUST, INC.
dei Trading Symbol
TradingSymbol
BXMT
us-gaap Additional Cash And Cash Equivalent Related Text
AdditionalCashAndCashEquivalentRelatedText
Cash and cash equivalents represent cash held in banks, cash on hand, and liquid investments with original maturities of three months or less.
us-gaap Management Fee Description
ManagementFeeDescription
Manager is entitled to an incentive fee in an amount equal to the product of (i) 20% and (ii) the excess of (a) our Core Earnings (as defined in the management agreement) for the previous 12-month period over (b) an amount equal to 7.00% per annum multiplied by our outstanding Equity, provided that our Core Earnings over the prior three-year period (or the period since the date of the first offering of our class A common stock following December 19, 2012, whichever is shorter) is greater than zero. Core Earnings is generally equal to our net income (loss) prepared in accordance with GAAP, excluding (i) certain non-cash items and (ii) the net income (loss) related to our legacy portfolio.
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
57460000
us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2016-12-30
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
28175003 shares
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may ultimately differ from those estimates.</p> </div>
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
45093314 shares
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 Segment
us-gaap Repurchase Agreement Counterparty Weighted Average Maturity Of Agreements1
RepurchaseAgreementCounterpartyWeightedAverageMaturityOfAgreements1
P2Y1M6D
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
us-gaap Deferred Revenue Description
DeferredRevenueDescription
Income accrual is generally suspended for loans at the earlier of the date at which payments become 90 days past due or when, in the opinion of our Manager, recovery of income and principal becomes doubtful.
dei Entity Central Index Key
EntityCentralIndexKey
0001061630
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.46
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
1.52
us-gaap Schedule Of Repurchase Agreements
ScheduleOfRepurchaseAgreements
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"> The following table outlines the key terms of our revolving repurchase facilities:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"><!-- Begin Table Head --> <tr> <td width="22%"></td> <td valign="bottom" width="10%"></td> <td></td> <td valign="bottom" width="10%"></td> <td></td> <td valign="bottom" width="10%"></td> <td></td> <td valign="bottom" width="10%"></td> <td></td> <td valign="bottom" width="10%"></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"> <td valign="bottom" nowrap="nowrap"> <p style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; WIDTH: 24.9pt"> <b>Lender</b></p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" nowrap="nowrap" align="center"><b>Rate<sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: top">(1)(2)</sup></b></td> <td valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" nowrap="nowrap" align="center"><b>Guarantee<sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: top">(1)(3)</sup></b></td> <td valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" nowrap="nowrap" align="center"><b>Advance Rate<sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: top">(1)</sup></b></td> <td valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" nowrap="nowrap" align="center"><b>Margin Call<sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: top">(4)</sup></b></td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" nowrap="nowrap" align="center"><b>Term/Maturity</b></td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top" nowrap="nowrap"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Wells Fargo</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center">L+1.85%</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center">25%</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center">78.47%</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center"> Collateral&#xA0;marks&#xA0;only</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center">Term matched<b><sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: top">(6)</sup></b></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top" nowrap="nowrap"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Bank of America</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center">L+1.75%</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center">50%</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center">79.57%</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center"> Collateral&#xA0;marks&#xA0;only</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center">May 21, 2019<b><sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: top">(5)</sup></b></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top" nowrap="nowrap"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Citibank</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center">L+1.94%</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center">25%</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center">76.06%</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center"> Collateral&#xA0;marks&#xA0;only</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center">Term matched<b><sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: top">(6)</sup></b></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top" nowrap="nowrap"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> JP Morgan</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center">L+1.98%</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center">25%</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center">77.37%</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center"> Collateral&#xA0;marks&#xA0;only</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center">Term matched<b><sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: top">(6)(7)</sup></b></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"> <td valign="top" nowrap="nowrap"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> MetLife</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center">L+1.82%</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center">50%</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center">77.64%</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center"> Collateral&#xA0;marks&#xA0;only</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center">June 29, 2020<b><sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: top">(8)</sup></b></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <td valign="top" nowrap="nowrap"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Morgan Stanley</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center">L+2.32%</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center">25%</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center">78.61%</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center"> Collateral&#xA0;marks&#xA0;only</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="center">March 3, 2017</td> </tr> <!-- End Table Body --></table> <p style="MARGIN-BOTTOM: 2pt; BORDER-BOTTOM: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt; LINE-HEIGHT: 8pt; WIDTH: 10%"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left">(1)</td> <td valign="top" align="left">Represents a weighted-average based on collateral assets pledged and borrowings outstanding as of September&#xA0;30, 2014.</td> </tr> </table> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left">(2)</td> <td valign="top" align="left">Represents weighted-average cash coupon on borrowings outstanding as of September&#xA0;30, 2014. As of September&#xA0;30, 2014, 91% of our revolving repurchase agreements are indexed to one-month USD LIBOR, 7% are indexed to three-month GBP LIBOR, and 2% referencing other floating rate indices.</td> </tr> </table> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left">(3)</td> <td valign="top" align="left">Other than amounts guaranteed based on specific collateral asset types, borrowings under our revolving repurchase facilities are not recourse to us.</td> </tr> </table> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left">(4)</td> <td valign="top" align="left">Margin call provisions under our revolving repurchase facilities do not permit valuation adjustments based on capital markets activity, and are limited to collateral-specific credit marks.</td> </tr> </table> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left">(5)</td> <td valign="top" align="left">Includes two one-year extension options which may be exercised at our sole discretion.</td> </tr> </table> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left">(6)</td> <td valign="top" align="left">These revolving repurchase facilities have various availability periods during which new advances can be made and which are generally subject to each lender&#x2019;s discretion. Maturity dates for advances outstanding are tied to the term of each respective collateral asset.</td> </tr> </table> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left">(7)</td> <td valign="top" align="left">Borrowings denominated in British pound sterling under this facility mature on December&#xA0;30, 2016.</td> </tr> </table> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left">(8)</td> <td valign="top" align="left">Includes five one-year extension options which may be exercised at our sole discretion.</td> </tr> </table> </div>
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-7003000
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
7000000
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
281000
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
7604000
us-gaap Profit Loss
ProfitLoss
75157000
bxmt Proceeds From Loan Origination And Exit Fees
ProceedsFromLoanOriginationAndExitFees
28015000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
24294000
us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
753100000
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
-14125000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
68154000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
281000
us-gaap Interest Expense
InterestExpense
47697000
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
124000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
763407000
us-gaap Proceeds From Payments For In Securities Sold Under Agreements To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase
2348197000
us-gaap Professional Fees
ProfessionalFees
1983000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
6842000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
0
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
12610000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
412000
us-gaap Increase Decrease In Payables Under Repurchase Agreements
IncreaseDecreaseInPayablesUnderRepurchaseAgreements
-1537138000
us-gaap Noninterest Expense
NoninterestExpense
35139000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
78810000
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
-13323000
us-gaap Restricted Stock Expense
RestrictedStockExpense
5554000
us-gaap Income Loss From Subsidiaries Tax Expense Benefit
IncomeLossFromSubsidiariesTaxExpenseBenefit
219000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1822250000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
763407000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1867100000
us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
69000
us-gaap Management Fee Expense
ManagementFeeExpense
13219000
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1503000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-1609000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21920000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
759000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-1398000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-7003000
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
13323000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
6602000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
2000000000
us-gaap Share Based Compensation
ShareBasedCompensation
6824000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
6602000
us-gaap Dividends Common Stock
DividendsCommonStock
70962000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
75569000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
55399000
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
2297545000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
61552000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
5552000
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
126507000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
12780000
us-gaap Net Income Loss
NetIncomeLoss
68555000
us-gaap Interest Paid
InterestPaid
35977000
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
20794000
us-gaap Proceeds From Sale And Collection Of Loans Receivable
ProceedsFromSaleAndCollectionOfLoansReceivable
403189000
bxmt Stock Issued During Period Shares Issuance Of Deferred Shares
StockIssuedDuringPeriodSharesIssuanceOfDeferredShares
15104 shares
bxmt General And Administrative Expenses Subtotal
GeneralAndAdministrativeExpensesSubtotal
3486000
bxmt Commitments Expiration Period
CommitmentsExpirationPeriod
P5Y
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
12763000
bxmt Incentive Fee Computation Percent Of Outstanding Equity Per Annum
IncentiveFeeComputationPercentOfOutstandingEquityPerAnnum
0.0700 pure
bxmt Management Incentive Awards Plan
ManagementIncentiveAwardsPlan
1010000
bxmt Closing Of Revolving Repurchase Facility
ClosingOfRevolvingRepurchaseFacility
3 Facility
bxmt Debt Instrument Covenant Minimum Percentage Of Tangible Net Worth On Net Cash Proceed Of Equity Issuances
DebtInstrumentCovenantMinimumPercentageOfTangibleNetWorthOnNetCashProceedOfEquityIssuances
0.75 pure
bxmt Computed Management Fee Percent Of Outstanding Equity Balance
ComputedManagementFeePercentOfOutstandingEquityBalance
0.0150 pure
bxmt Net Taxable Income Subject To Distribution Percent
NetTaxableIncomeSubjectToDistributionPercent
1.00 pure
bxmt Net Change In Accrued Interest Receivable Prepaid Expenses And Other Assets
NetChangeInAccruedInterestReceivablePrepaidExpensesAndOtherAssets
-8184000
bxmt Excise Tax Rate
ExciseTaxRate
0.04 pure
bxmt Repayment Of Borrowings On Repurchase Agreements
RepaymentOfBorrowingsOnRepurchaseAgreements
181858000
bxmt Closing Of Asset Specific Repurchase Facilities
ClosingOfAssetSpecificRepurchaseFacilities
1 Assets
bxmt Operating Losses Carryforwards Expiration Dates
OperatingLossesCarryforwardsExpirationDates
Expire in 2029
bxmt Proceeds From Sale Of Loan Participation
ProceedsFromSaleOfLoanParticipation
368850000
bxmt Participations Sold Loan Coupon Rate Description
ParticipationsSoldLoanCouponRateDescription
L+3.01 %
bxmt Participations Sold Loan Yield Description
ParticipationsSoldLoanYieldDescription
L+3.22 %
bxmt Expenses Of Consolidated Securitization Vehicles
ExpensesOfConsolidatedSecuritizationVehicles
399000
CY2014Q3 bxmt Non Cash And Legacy Compensation Expenses
NonCashAndLegacyCompensationExpenses
2077000
bxmt Plan Adoption Date
PlanAdoptionDate
March 25, 2014
bxmt Number Of Loan Participations Sold
NumberOfLoanParticipationsSold
3 Participants
bxmt Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
7357000
bxmt Incentive Fee Computation Percent Of Product Per Agreement
IncentiveFeeComputationPercentOfProductPerAgreement
0.20 pure
bxmt Annual Distribution Of Net Taxable Income Percentage
AnnualDistributionOfNetTaxableIncomePercentage
0.90 pure
bxmt Underlying Loans Yield Description
UnderlyingLoansYieldDescription
L+5.81 %
bxmt Management Incentive Awards Plan Paid In Cash
ManagementIncentiveAwardsPlanPaidInCash
11190000
bxmt Number Of Loans Underlying
NumberOfLoansUnderlying
3 Participants
bxmt Underlying Loans Coupon Rate Description
UnderlyingLoansCouponRateDescription
L+4.56 %
bxmt Proceeds From Borrowings Under Asset Repurchase Agreements
ProceedsFromBorrowingsUnderAssetRepurchaseAgreements
163088000
bxmt Loan Participation Sold
LoanParticipationSold
368850000
bxmt Non Cash And Legacy Compensation Expenses
NonCashAndLegacyCompensationExpenses
18035000
CY2014Q3 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-8932000
CY2014Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
1780000
CY2014Q3 us-gaap Profit Loss
ProfitLoss
23601000
CY2013 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
0
CY2013 bxmt Participations Sold Loan Coupon Rate Description
ParticipationsSoldLoanCouponRateDescription
L+5.12 %
CY2013 bxmt Participations Sold Loan Yield Description
ParticipationsSoldLoanYieldDescription
L+5.26 %
CY2013 bxmt Number Of Loan Participations Sold
NumberOfLoanParticipationsSold
1 Participants
CY2013 bxmt Underlying Loans Yield Description
UnderlyingLoansYieldDescription
L+9.25 %
CY2013 bxmt Number Of Loans Underlying
NumberOfLoansUnderlying
1 Participants
CY2013 bxmt Underlying Loans Coupon Rate Description
UnderlyingLoansCouponRateDescription
L+5.66 %
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
28894515 shares
CY2013Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.27
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23483000
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13092000
CY2014Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
50386000
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.29
CY2013Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
14446000
CY2013Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
464000
CY2013Q3 us-gaap Profit Loss
ProfitLoss
10526000
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10262000
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8320000
CY2013Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
18853000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
8320000
CY2013Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
10526000
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
94000
CY2013Q3 us-gaap Interest Expense
InterestExpense
4407000
CY2013Q3 us-gaap Professional Fees
ProfessionalFees
843000
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-264000
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
22024000
CY2014Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
14669000
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
94000
CY2014Q3 us-gaap Interest Expense
InterestExpense
19903000
CY2014Q3 us-gaap Professional Fees
ProfessionalFees
701000
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-118000
CY2014Q3 us-gaap Noninterest Expense
NoninterestExpense
8780000
CY2014Q3 us-gaap Restricted Stock Expense
RestrictedStockExpense
1525000
CY2014Q3 us-gaap Management Fee Expense
ManagementFeeExpense
5412000
CY2014Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
461000
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3368000
CY2014Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1577000
CY2014Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1577000
CY2014Q3 bxmt General And Administrative Expenses Subtotal
GeneralAndAdministrativeExpensesSubtotal
1162000
CY2014Q3 bxmt Management Incentive Awards Plan
ManagementIncentiveAwardsPlan
458000
CY2014Q3 bxmt Expenses Of Consolidated Securitization Vehicles
ExpensesOfConsolidatedSecuritizationVehicles
129000
CY2013Q3 us-gaap Noninterest Expense
NoninterestExpense
4048000
CY2013Q3 us-gaap Management Fee Expense
ManagementFeeExpense
2433000
CY2013Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
148000
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1615000
CY2013Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2206000
CY2013Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
2206000
CY2013Q3 bxmt General And Administrative Expenses Subtotal
GeneralAndAdministrativeExpensesSubtotal
991000
CY2013Q3 bxmt Reversal Of Provision For Loan Lease And Other Losses
ReversalOfProvisionForLoanLeaseAndOtherLosses
-600000
CY2013Q3 bxmt Management Incentive Awards Plan
ManagementIncentiveAwardsPlan
458000
CY2013Q3 bxmt Expenses Of Consolidated Securitization Vehicles
ExpensesOfConsolidatedSecuritizationVehicles
72000
CY2013Q3 bxmt Non Cash And Legacy Compensation Expenses
NonCashAndLegacyCompensationExpenses
552000
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
49211205 shares
CY2014Q3 us-gaap Repurchase Agreement Counterparty Weighted Average Maturity Of Agreements1
RepurchaseAgreementCounterpartyWeightedAverageMaturityOfAgreements1
P2Y1M6D
CY2014Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.50
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.45
CY2014Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
30483000

Files In Submission

Name View Source Status
0001193125-14-385002-index-headers.html Edgar Link pending
0001193125-14-385002-index.html Edgar Link pending
0001193125-14-385002.txt Edgar Link pending
0001193125-14-385002-xbrl.zip Edgar Link pending
bxmt-20140930.xml Edgar Link completed
bxmt-20140930.xsd Edgar Link pending
bxmt-20140930_cal.xml Edgar Link unprocessable
bxmt-20140930_def.xml Edgar Link unprocessable
bxmt-20140930_lab.xml Edgar Link unprocessable
bxmt-20140930_pre.xml Edgar Link unprocessable
d792445d10q.htm Edgar Link pending
d792445dex101.htm Edgar Link pending
d792445dex102.htm Edgar Link pending
d792445dex103.htm Edgar Link pending
d792445dex104.htm Edgar Link pending
d792445dex31.htm Edgar Link pending
d792445dex311.htm Edgar Link pending
d792445dex312.htm Edgar Link pending
d792445dex32.htm Edgar Link pending
d792445dex321.htm Edgar Link pending
d792445dex322.htm Edgar Link pending
d792445dex991.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g792445g58d21.jpg Edgar Link pending
g792445gp008.jpg Edgar Link pending
g792445tx_pg001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending